The Role of Interleukin-converting Enzyme in Fas-mediated Apoptosis in HIV-1 Infection
Overview
Affiliations
Apoptosis of CD4+ lymphocytes is partially responsible for the depletion of these cells in HIV-infected individuals. CD4+ lymphocytes from HIV-1-infected patients express higher membrane levels of the Fas receptor, and are particularly susceptible to apoptosis after Fas triggering. IL-1beta- converting enzyme (ICE) is a key enzyme of the apoptotic machinery involved in Fas-mediated apoptosis of normal lymphocytes. The role of ICE in mediating the increased susceptibility of CD4+ lymphocytes from HIV-1-infected patients to apoptosis has not been examined. In this study, we found that ICE mRNA was present in T cells from both HIV-1-infected patients and controls. Active ICE proteins, p10 and p20, were demonstrated by immunoblot in lymphocytes from HIV-1-infected patients and in normal lymphocytes after treatment with Fas agonist, CH11 mAb. Cocultivation of lymphocytes from HIV-1-infected persons with Fas antagonist, antibody ZB4, resulted in decreased expression of ICE protein in lymphocytes from HIV-infected patients, and decreased apoptosis. Similar effects were obtained when cells were treated with synthetic ICE inhibitors, which blocked apoptosis in response to Fas triggering. When CD4+ and CD8+ cells were sorted by flow cytometry and analyzed by reverse transcriptase PCR, ICE mRNA was present in both CD8+ and CD4+ cells. However, flow cytometric analysis of lymphocytes with intracellular staining for ICE demonstrated ICE protein in the CD4+ but not the CD8+ cell fraction derived from blood of HIV-1-infected patients. These data suggest that activation of ICE occurs in vivo in CD4+ lymphocytes from HIV-1-infected individuals, and may account for the increased susceptibility of CD4+ cells to apoptosis.
Laforge M, Silvestre R, Rodrigues V, Garibal J, Campillo-Gimenez L, Mouhamad S J Clin Invest. 2018; 128(4):1627-1640.
PMID: 29553486 PMC: 5873886. DOI: 10.1172/JCI95127.
Some findings of FADD knockdown in inhibition of HIV-1 replication in Jurkat cells and PBMCs.
Wang X, Tan J, Zhao J, Ragupathy V, Haleyurgirisetty M, Hewlett I Mol Cell Biochem. 2014; 393(1-2):181-90.
PMID: 24752353 DOI: 10.1007/s11010-014-2058-7.
Priceputu E, Rodrigue I, Chrobak P, Poudrier J, Mak T, Hanna Z J Virol. 2005; 79(10):6377-91.
PMID: 15858021 PMC: 1091671. DOI: 10.1128/JVI.79.10.6377-6391.2005.
Landay A, Benning L, Bremer J, Weiser B, Burger H, Nowicki M J Infect Dis. 2003; 188(2):209-18.
PMID: 12854075 PMC: 3164115. DOI: 10.1086/376509.
Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death.
Estaquier J, Lelievre J, Petit F, Brunner T, Moutouh-de Parseval L, Richman D J Virol. 2002; 76(12):5966-73.
PMID: 12021329 PMC: 136220. DOI: 10.1128/jvi.76.12.5966-5973.2002.